Search clinical trials for: thymalfasin (thymosin alpha 1)

Total 1717 results

Northeast College of Health Sciences

Completed

The Effects of Glucomannan on Weight Loss

Obesity
Kamada, Ltd.

Completed

Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients

Cystic Fibrosis

Israel
Assiut University

Not yet recruiting

Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women

Pre-Eclampsia | Intrauterine Growth Restriction | alpha1 Anti-trypsin
Instituto Grifols, S.A.

Completed

Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19

COVID-19

Spain
CSL Behring

Completed

Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.

Emphysema | Alpha 1-proteinase Inhibitor Deficiency

Australia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
Andrew Hendifar, MD
Janssen Research & Development, LLC; Ipsen

Completed

Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia (OnFX)

Pancreatic Cancer | Weight Loss | Cachexia

United States
Unity Health Toronto

Unknown

Effects of Viscous Fibre Containing Foods on Satiety (Gel Form)

Obesity

Canada
Hospital Universitari Vall d'Hebron Research Institute
Bayer; Sociedad Española de Neumología y Cirugía Torácica; Instituto de Salud...

Completed

Inhaled A1AT in Adult Stable Bronchiectasis

Bronchiectasis Adult
Pfizer

Completed

Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules

Heart Failure | Hypertension

United States
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
Universität des Saarlandes

Completed

Alpha-1-Antitrypsin-Deficiency in COVID-19 (CORSAAR-AAT)

Covid19

Germany
University of Rostock

Unknown

AKI Cardiosurgery Diagnostic Study (AKI-CDS) (AKI-CDS)

Acute Kidney Injury | Renal Replacement Therapy

Germany
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Recruiting

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma

Refractory Melanoma | HLA-A2 Positive Cells Present

United States
Sengkang General Hospital

Not yet recruiting

Tamsulosin Assisted Ureteral Access Sheath Insertion

Urolithiasis | Retrograde Intrarenal Surgery | Renal Stone
JW Pharmaceutical

Completed

Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH

Benign Prostatic Hypertrophy

Korea, Republic of
Seoul National University Hospital

Completed

Prevention of Acute Voiding Difficulty After Radical Proctectomy

Rectal Cancer | Urinary Retention

Korea, Republic of
Sanofi

Completed

Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin (SAMBA-Thailand)

Prostatic Hyperplasia

Thailand
Sanofi

Terminated

ALF-STONE: Alfuzosin in Uretheric Stones

Prostatic Hyperplasia

Portugal
Sanofi

Terminated

Alfuzosin Versus Placebo in Acute Urinary Retention (ALF-RIK)

Urinary Retention

Denmark
Hadassah Medical Organization

Unknown

Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin

Upper Tract Ureterolithiasis

Israel
Kamada, Ltd.
Syneos Health

Recruiting

Evaluate Efficacy and Safety of "Kamada-AAT for Inhalation" in Patients With AATD (InnovAATe)

Alpha 1-Antitrypsin Deficiency

United Kingdom, Sweden, Ireland, Netherlands, Belgium, Finland
Syrian Private University

Completed

Silodosin in Management of Lower Ureteral Stones

Stone, Kidney

Syrian Arab Republic
Centre Hospitalier Departemental Vendee

Terminated

Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm. (SiloMET)

Kidney Stone | Expulsive Medical Therapy

France
Sanofi

Completed

SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

Prostatic Hyperplasia

Colombia, Mexico, Ecuador, Guatemala
Medical University of Warsaw

Completed

Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood

Functional Gastrointestinal Disorders

Poland
Blessing Corporate Services, Inc
Takeda Pharmaceuticals North America, Inc.

Withdrawn

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Pneumonia, Viral | Covid19

United States
Unity Health Toronto
University of Toronto; Dicofarm

Completed

Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM

Coronary Heart Disease | Type2 Diabetes
M.D. Anderson Cancer Center

Terminated

Doxercalciferol in Recurrent Pediatric Solid Tumors

Solid Tumors

United States
Mayo Clinic
National Cancer Institute (NCI)

Withdrawn

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

Hematopoietic and Lymphoid Cell Neoplasm | Sarcoma | Lymphoma | Breast Carcinoma

United States
Centre Hospitalier Universitaire de Nīmes

Recruiting

Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women (ALPHA-SEP)

Multiple Sclerosis | Lower Urinary Tract Symptoms | Urinary Retention | Voiding Dysfunction | Dysuria

France
National Institute of Diabetes and Digestive and...
University of California, San Diego; The Cleveland Clinic; Duke University; University... and other collaborators

Recruiting

Vitamin E Dosing Study (VEDS)

Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis

United States
Sheba Medical Center

Recruiting

Tamsulosin for Thyroid Lid Retraction

Thyroid Eye Disease | Eyelid Diseases

Israel
Wake Forest University Health Sciences

Terminated

The Effect of Tamsulosin on Postoperative Urinary Retention

Urinary Retention

United States
Mansoura University

Active, not recruiting

The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis

Stone, Kidney | Pediatric Disorder | Stone, Urinary | Extracorporeal Shock Wave Lithotripsy | Tamsulosin

Egypt
University of Manitoba

Suspended

Prazosin Use in Adults With Anxiety Disorders

Anxiety Disorders | Anxiety

Canada
Milton S. Hershey Medical Center

Completed

Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

Stress Disorders, Post-Traumatic | Bulimia Nervosa

United States
Augusta University

Completed

Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD) (REST-ON PTSD)

Suicidal Ideation | Post Traumatic Stress Disorder | Nightmares

United States
Rennes University Hospital
Ministry of Health, France; Yamanouchi

Completed

Evaluation of Tamsulosin in the Treatment of Ureteral Stones (TAMSULOSINE)

Ureteral Calculi | Ureterolithiasis

France
JW Pharmaceutical

Completed

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

Neurogenic Bladder | Voiding Dysfunction

Korea, Republic of
Sanofi

Completed

ALF-ONE : ALFuzosin ONcE Daily

Prostatic Hyperplasia
Cedars-Sinai Medical Center

Recruiting

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

REM Sleep Behavior Disorder | Pre-motor Parkinson's Disease | Symptomatic Parkinson Disease

United States
University of Iowa
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Target Engagement of Terazosin in Healthy Adults

Healthy

United States
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Memorial Health University Medical Center

Unknown

Hernia Surgery Urinary Retention

Hernia | Urinary Retention

United States
Chesapeake Urology Research Associates
Sanofi

Completed

An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Erectile Dysfunction

United States
Boehringer Ingelheim

Completed

Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
RECORDATI GROUP

Completed

Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (SiRE)

Benign Prostatic Hyperplasia

Italy
Sanofi

Completed

Once Daily Given Alfuzosin in the Treatment of BPH

Benign Prostatic Hyperplasia

Hungary
Sanofi

Completed

Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy

BPH/LUTS/Sexual Functions

Korea, Republic of
Sanofi

Completed

The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score (ALF-ACUTE)

Benign Prostatic Hyperplasia

United States

Search clinical trials for: thymalfasin (thymosin alpha 1)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations